Could Two-Drug cocktails tame stubborn inflammatory bowel disease?
NCT ID NCT07697456
First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time
Summary
This study tests whether combining risankizumab with either trosunilimab or ABBV-701 can safely reduce inflammation and improve symptoms in adults with moderately to severely active Crohn's disease or ulcerative colitis. Participants are randomly assigned to one of the combination treatments or a placebo. The goal is to see if these advanced therapies can achieve endoscopic remission, meaning the gut lining heals.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- risankizumab, trosunilimab, and ABBV-701
- What this could lead to
- If successful, these combination therapies could offer new treatment options for people with hard-to-control inflammatory bowel disease.
- What could go wrong
- This is an early-phase trial with a limited number of participants per arm, so results may not apply to everyone. Side effects are possible, and the combinations may not prove more effective than existing treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN'S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AZ-Delta. /ID# 281031
Roeselare, West-Vlaanderen, 8800, Belgium
-
Auzmer Research /ID# 280786
Lakeland, Florida, 33813, United States
-
CHU de Liege /ID# 281182
Liège, 4000, Belgium
-
Chris Hani Baragwanath Hospital /ID# 284122
Johannesburg, Gauteng, 1864, South Africa
-
Chu De Charleroi - Hopital Civil Marie Curie /ID# 281632
Lodelinsart, Hainaut, 6042, Belgium
-
Digestive Disease Consultants - Brunswick /ID# 283935
Brunswick, Ohio, 44212, United States
-
Excellentis Clinical Trial Consultants /ID# 282430
George, Western Cape, 6529, South Africa
-
Gastro Health - Miami /ID# 282001
Miami, Florida, 33176, United States
-
Gi Alliance - Texas Digestive Disease Consultants - San Marcos /ID# 283947
San Marcos, Texas, 78666, United States
-
Gold Coast Hospital /ID# 282434
Southport, Queensland, 4215, Australia
-
Hackensack Meridian Health - Hackensack University Medical Center /ID# 281865
Hackensack, New Jersey, 07601, United States
-
Hospital Galdakao-Usansolo /ID# 280388
Galdakao, Vizcaya, 48960, Spain
-
Hospital Rio Hortega /ID# 281426
Valladolid, 47012, Spain
-
Hospital Universitario Reina Sofia /ID# 281446
Córdoba, 14004, Spain
-
Iwate Medical University Hospital /ID# 282387
Shiwa-gun, Iwate, 028-3695, Japan
-
John Hunter Hospital /ID# 282537
Newcastle, New South Wales, 2305, Australia
-
Lenasia Clinical Trial Centre - Johannesburg /ID# 281415
Johannesburg, Gauteng, 1821, South Africa
-
Macquarie Hospital /ID# 281739
Macquarie University, New South Wales, 02109, Australia
-
Mater Hospital Brisbane /ID# 281738
South Brisbane, Queensland, 4101, Australia
-
Monash Health - Monash Medical Centre - Clayton /ID# 281711
Clayton, Victoria, 3168, Australia
-
Portland Gastroenterology Center - Portland - Congress Street /ID# 281970
Portland, Maine, 04102, United States
-
Queens Village Primary Medical Center /ID# 281857
New York, New York, 11428, United States
-
Skyline Gastroenterology of West Tennessee /ID# 284146
Jackson, Tennessee, 38301, United States
-
Takagi Clinic - Sendai /ID# 281805
Sendai, Miyagi, 981-3213, Japan
-
Texas Digestive Disease Consultants /ID# 284159
Austin, Texas, 78731, United States
-
Universitaetsklinikum Tuebingen /ID# 282958
Tübingen, Baden-Wurttemberg, 72076, Germany
-
Universitair Ziekenhuis Antwerpen /ID# 282218
Edegem, Antwerpen, 2650, Belgium
-
Universite Catholique de Louvain-Namur - Centre Hospitalier Universitaire Dinant /ID# 281312
Yvoir, Namur, 5530, Belgium
-
University Hospital Zurich /ID# 280548
Zurich, Canton of Zurich, 8091, Switzerland
-
University Medical Centre Maribor /ID# 281175
Maribor, 2000, Slovenia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a probiotic enema heal the gut lining in ulcerative colitis?
- Amniotic cell secretions may fight gut inflammation and scarring — a lab study puts them to the test
- Could a diet change calm IBD by reshaping gut bacteria?
- Experimental drug aims to quiet gut inflammation in ulcerative colitis
- Two-Drug cocktail aims to tame stubborn Crohn's disease
- Medical records reveal clues to treating stubborn inflammatory bowel disease